Product Information
ATORVASTATIN 40 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0379 per EA under NDC 16571013809. Its NADAC has been published 122 times since Feb 28, 2024.
Strength
40 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571013809
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ATORVASTATIN CALCIUM TRIHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA209912On Market Since
10/20/2023
Pharmacological Classes
Price Statistics
The NADAC for ATORVASTATIN 40 MG TABLET has been published 122 times since Feb 28, 2024, and over the history we have for it it has declined 44.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0379 per EA |
|---|---|
| All-time high | $0.0684 (Mar 13, 2024) |
| All-time low | $0.0379 (Jun 17, 2026) |
| 52-week high | $0.0463 |
| 52-week low | $0.0379 |
| Median price | $0.0459 |
| Average price | $0.0465 |
| Largest weekly change | +27.7% (Aug 21, 2024) |
| Weeks tracked | 122 |
| Tracking since | Feb 28, 2024 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ATORVASTATIN 40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ATORVASTATIN 40 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.0379 per EA (NDC 16571013809), effective Jun 24, 2026.
How has the price of ATORVASTATIN 40 MG TABLET changed over time?
Over the history we have for it, the NADAC for ATORVASTATIN 40 MG TABLET has declined 44.6%. It has been tracked across 122 weekly CMS publications since Feb 28, 2024.
What are the highest and lowest recorded NADAC prices for ATORVASTATIN 40 MG TABLET?
Since Feb 28, 2024, the NADAC for ATORVASTATIN 40 MG TABLET has ranged from a low of $0.0379 (Jun 17, 2026) to a high of $0.0684 (Mar 13, 2024), with a median of $0.0459 per EA.
Are there cheaper alternatives to ATORVASTATIN 40 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as ATORVASTATIN 40 MG TABLET, but none are currently priced below it.
Who manufactures ATORVASTATIN 40 MG TABLET?
ATORVASTATIN 40 MG TABLET (NDC 16571013809) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification